سعر تاروكساترون 500مجم/5مل 6 امبولات 2023

Tranexamic acid 500 mg/5 mL (100 mg/mL) solution for injection in ampoules (Global Pharmaceutical Industries); pack of 6 ampoules.

• Patients with haemophilia, short-term use (2-8 days) to reduce or prevent haemorrhage and reduce the need for replacement therapy during and after tooth extraction.DailyMed (U.S. National Library of Medicine)

• Neuraxial (intrathecal/epidural) injection; subarachnoid haemorrhage; active intravascular clotting; hypersensitivity to tranexamic acid.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: risk of medication errors due to incorrect route - for IV use only; inadvertent neuraxial administration caused seizures, arrhythmias and death.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Thromboembolic risk (avoid with prothrombotic products incl. factor IX complex and hormonal contraceptives), seizures, hypersensitivity, visual disturbances and dizziness.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Prothrombotic medical products (e.g. factor IX complex, hormonal contraceptives)Avoid concomitant use: increased thromboembolic risk.DailyMed (U.S. National Library of Medicine)

• Published data in 2nd/3rd trimester and at delivery have not clarified a drug-associated risk of miscarriage or adverse outcomes.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Tranexamic acid is present in human milk; no data on effects on the breastfed child.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Tranexamic acid: Inhibits plasminogen activation / plasmin fibrinolytic activity (UK Cyklokapron SmPC).